“In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis”, ADMET DMPK, vol. 6, no. 2, pp. 176–189, Jun. 2018, doi: 10.5599/admet.547.